Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
Keywords :
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
location
Contact Email
Phone number
Website URL
Similar Companies1000
Kleo
Kleo Pharmaceuticals develops immunotherapy compounds to target cancer cells.
Sector
Subsector
Location
total rounds
total raised
Adriacell
Adriacell is a biotech company focused on developing solutions for tumors with low survival rates and anti-infective agents.
Sector
Subsector
Keywords
Location
Immune Biosolutions
Immune Biosolutions is a biotech company that specializes in the discovery and engineering of chicken edible and humanized antibodies.
Sector
Subsector
Keywords
Location
total rounds
total raised
A2A Pharmaceuticals
A2A Pharmaceuticals Inc.
Sector
Subsector
Keywords
Location
total rounds
M&A Details1
Transaction name
Acquired by
Johnson & Johnson
announced date
price
Financials
Funding Rounds3
Number of Funding Rounds
Money Raised
Their latest funding was raised on 01.09.2009. Their latest round Post-IPO Equity
Polaris Partners
Polaris Partners is a venture capital firm that invests in healthcare and technology companies at all stages of growth.
Sector
Subsector
Location
count Of Investments
count Of Exists
MVM Life Science Partners
MVM Life Science Partners is a venture capital firm that invests in healthcare companies.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Cardinal Partners
Cardinal Partners is a venture capital firm based in Princeton, New Jersey, that invests in early-stage companies in the healthcare sector.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Mithra Ventures
Mithra Group is a venture capital firm that invests in high-growth life sciences companies in the US and India.
Sector
Subsector
Location
count Of Investments
count Of Exists
Atlas Venture
Atlas Venture invests in biotech startups with seed and early stage venture investments.
Sector
Subsector
Keywords
Location
total rounds
count Of Investments
count Of Exists
Cardinal Partners
Cardinal Partners is a venture capital firm based in Princeton, New Jersey, that invests in early-stage companies in the healthcare sector.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
MVM Life Science Partners
MVM Life Science Partners is a venture capital firm that invests in healthcare companies.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Atlas Venture
Atlas Venture invests in biotech startups with seed and early stage venture investments.
Sector
Subsector
Keywords
Location
total rounds
count Of Investments
count Of Exists
Polaris Partners
Polaris Partners is a venture capital firm that invests in healthcare and technology companies at all stages of growth.
Sector
Subsector
Location
count Of Investments
count Of Exists
Co-Investors
Investors5
Number of lead investors
Number of investors
Cardinal Partners
Cardinal Partners is a venture capital firm based in Princeton, New Jersey, that invests in early-stage companies in the healthcare sector.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
MVM Life Science Partners
MVM Life Science Partners is a venture capital firm that invests in healthcare companies.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Atlas Venture
Atlas Venture invests in biotech startups with seed and early stage venture investments.
Sector
Subsector
Keywords
Location
total rounds
count Of Investments
count Of Exists
Peter Barrett
Barrett joined Atlas Venture, an early stage life sciences venture capital fund, in 2002 and is a partner in the life sciences group. Previously, he was a co-founder, Executive Vice President and Chief Business Officer of Celera Genomics. Prior to that, Mr. Barrett held several senior management positions at The Perkin-Elmer Corporation, most recently serving as Vice President, Corporate Planning and Business Development. He currently serves as a director of Vitae Pharmaceuticals, Inc. and Zafgen, Inc., as well as several privately held companies, and during the past five years has served as a director of Akela Pharma, Inc., Alnylam Pharmaceuticals, Inc., Helicos BioSciences Corporation, Momenta Pharmaceuticals, Inc. and SciClone Pharmaceuticals, Inc. Mr. Barrett is currently Vice Chairman of the Advisory Council of the Barrett Institute of Chemical and Biological Analysis at Northeastern University, as well as Adjunct Professor at the Barrett Institute. He also serves as President of the Autism Consortium, a non-profit institution. Mr. Barrett received his Bachelor of Science degree in chemistry from Lowell Technological Institute (now known as the University of Massachusetts, Lowell) and his Doctoral degree in analytical chemistry from Northeastern University. Mr. Barrett has approximately 25 years of experience in the life sciences industry, having served in leadership positions both as a senior executive and as an institutional investor. These roles have allowed him to develop expertise in the deployment of strategic growth initiatives within the industry. His service on the board of directors of other companies, both publicly traded and privately held, enables him to assist our board in the performance of its governance obligations.
current job
count Of Investments
count Of Exists
Acquisitions2
Virdante Pharmaceuticals acquired by Momenta Pharmaceuticals
acquirer
date
type
price
Virdante Pharmaceuticals
Virdante Pharmaceuticals develops and commercializes drugs for autoimmune and inflammatory diseases.
Sector
Subsector
Keywords
Location
total rounds
total raised
Parivid acquired by Momenta Pharmaceuticals
acquirer
date
type
Parivid
Parivid offers data integration and analysis services.
Sector
Subsector
Location
People
Founders5
Ganesh Venkataraman Kaundinya
Dr. Ganesh Venkataraman Kaundinya, Ph.D., is Senior Vice President - Research, Chief Scientific Officer of Momenta Pharmaceuticals Inc. He is a co-founder of our company and has been our Chief Scientific Officer since September 2007 and our Senior Vice President, Research since April 2005. From January 2002 through April 2005, he served as our Vice President, Technology. Dr. Kaundinya received his M.S. and Ph.D. in Chemical Engineering from the Massachusetts Institute of Technology.
current job
organization founded
Ganesh Venkataraman Kaundinya
Mallik Sundaram
Dr. Mallik Sundaram co-founded Mitra Biotech in 2008. He serves as the President & CEO of Mitra Biotech since May 2008. Prior to Mitra, Mallik was a scientific co-founder of Momenta Pharmaceuticals (Nasdaq: MNTA) which was founded on the sequencing technology for Complex polysaccharides and glycoproteins, co-developed by Mallik at Dr. Sasisekharan laboratory at MIT. Mallik was instrumental in developing M-Enoxaparin, Momenta’s first Billion dollar drug and three other lead drug candidates through various stages of regulatory approval in the U.S. Mallik obtained his Ph.D. in Biotechnology from the University of Utah, Salt Lake City, and MBA from the Wharton Business School, University of Pennsylvania. He has been an adjunct faculty in the Department of Bioengineering (2000-2007) and the Department of Chemical Engineering (2007-present) at the Massachusetts Institute of Technology, Cambridge, MA.
current job
organization founded
Mallik Sundaram
Christoph Westphal
Christoph Westphal is the Co-Founder, Chairman & Board Member at ImmuneID.
current job
Christoph Westphal
Employee Profiles159
Rao Koduri
Associate director, downstream process development
James Prescott
Senior director analytical development
Kelly Beaumont
Executive assistant, legal and finance
Aleksandar Cvetkovic
Senior director, head of bioprocess development